These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16201181)

  • 1. [Enhancement of bacillus Calmette-Guerin attachment to the bladder wall: experimental study].
    Shen Z; Ding G; Chen Z
    Zhonghua Wai Ke Za Zhi; 2001 Dec; 39(12):951-3. PubMed ID: 16201181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study on enhancement of fibronectin-mediated bacillus Calmette-Guérin attachment to urinary bladder wall in rabbits.
    Shen ZJ; Wang Y; Ding GQ; Pan CW; Zheng RM
    World J Urol; 2007 Oct; 25(5):525-9. PubMed ID: 17665201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical investigation on the effect of intravesical instillation of antifibrinolytic agents with bacillus Calmette-Guerin on preventing bladder cancer recurrence].
    Ding GQ; Shen ZJ; Lu J; Jin XD; Chen J; Shi SF
    Zhonghua Wai Ke Za Zhi; 2005 Nov; 43(22):1457-60. PubMed ID: 16318813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of fibronectin-mediated Bacillus Calmette-Guérin attachment to murine bladder mucosa by drugs influencing the coagulation pathways.
    Hudson MA; Brown EJ; Ritchey JK; Ratliff TL
    Cancer Res; 1991 Jul; 51(14):3726-32. PubMed ID: 2065329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental study on attachment of bacillus Calmette-Guerin to bladder wall with different types of injury].
    Ding GQ; Shen ZJ; Chen ZD
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 33(1):65-7. PubMed ID: 14966944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of intravesical instillation of antifibrinolytic agents on bacillus Calmette-Guerin treatment of superficial bladder cancer: a pilot study.
    Pan CW; Shen ZJ; Ding GQ
    J Urol; 2008 Apr; 179(4):1307-11; discussion 1311-2. PubMed ID: 18289576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravesical Bacillus Calmette-Guérin therapy for murine bladder tumors: initiation of the response by fibronectin-mediated attachment of Bacillus Calmette-Guérin.
    Ratliff TL; Palmer JO; McGarr JA; Brown EJ
    Cancer Res; 1987 Apr; 47(7):1762-6. PubMed ID: 3545453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacterial adherence and BCG treatment of superficial bladder cancer.
    Schamhart DH; de Boer EC; Bevers RF; Kurth KH; Steerenberg PA
    Prog Clin Biol Res; 1992; 378():75-80. PubMed ID: 1284504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of mycobacteremia by intravesical bacillus Calmette-Guerin instillation in an experimental animal model and detection with polymerase chain reaction.
    Aygün C; Ozen H; Kocagöz T; Saribaş Z; Aki T; Tekin I
    J Urol; 2000 May; 163(5):1588-90. PubMed ID: 10751893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibronectin-mediated Calmette-Guerin bacillus attachment to murine bladder mucosa. Requirement for the expression of an antitumor response.
    Kavoussi LR; Brown EJ; Ritchey JK; Ratliff TL
    J Clin Invest; 1990 Jan; 85(1):62-7. PubMed ID: 2404029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravesical instillation therapy with bacillus Calmette-Guérin for superficial bladder cancer: study of the mechanism of bacillus Calmette-Guérin immunotherapy.
    Shintani Y; Sawada Y; Inagaki T; Kohjimoto Y; Uekado Y; Shinka T
    Int J Urol; 2007 Feb; 14(2):140-6. PubMed ID: 17302571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of bacillus Calmette-Guerin attachment to the urothelium by removal of the rabbit bladder mucin layer.
    Badalament RA; Franklin GL; Page CM; Dasani BM; Wientjes MG; Drago JR
    J Urol; 1992 Feb; 147(2):482-5. PubMed ID: 1732628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can early single dose instillation of epirubicin improve bacillus Calmette-Guerin efficacy in patients with nonmuscle invasive high risk bladder cancer? Results from a prospective, randomized, double-blind controlled study.
    Cai T; Nesi G; Tinacci G; Zini E; Mondaini N; Boddi V; Mazzoli S; Bartoletti R
    J Urol; 2008 Jul; 180(1):110-5. PubMed ID: 18485394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrin clot inhibitor medication and efficacy of bacillus Calmette-Guerin for bladder urothelial cancer.
    Boorjian SA; Berglund RK; Maschino AC; Savage CJ; Herr HW
    J Urol; 2009 Oct; 182(4):1306-12. PubMed ID: 19683284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of sequential intravesical administration of mitomycin C and bacillus Calmette-Guérin on the immune response in the guinea pig bladder.
    Balemans LT; Vegt PD; Steerenberg PA; De Boer EC; Van Swaaij A; De Vries RE; Van der Meijden AP; Den Otter W
    Urol Res; 1994; 22(4):239-45. PubMed ID: 7871637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term efficacy of maintenance bacillus Calmette-Guérin versus maintenance mitomycin C instillation therapy in frequently recurrent TaT1 tumours without carcinoma in situ: a subgroup analysis of the prospective, randomised FinnBladder I study with a 20-year follow-up.
    Järvinen R; Kaasinen E; Sankila A; Rintala E;
    Eur Urol; 2009 Aug; 56(2):260-5. PubMed ID: 19395154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative efficacy of various exogenous glycosaminoglycans in providing a bladder surface permeability barrier.
    Nickel JC; Downey J; Morales A; Emerson L; Clark J
    J Urol; 1998 Aug; 160(2):612-4. PubMed ID: 9679938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased infiltration of tumor associated macrophages is associated with poor prognosis of bladder carcinoma in situ after intravesical bacillus Calmette-Guerin instillation.
    Takayama H; Nishimura K; Tsujimura A; Nakai Y; Nakayama M; Aozasa K; Okuyama A; Nonomura N
    J Urol; 2009 Apr; 181(4):1894-900. PubMed ID: 19237175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoprotection against murine bladder carcinoma by octaarginine-modified liposomes incorporating cell wall of Mycobacterium bovis bacillus Calmette-Guérin.
    Joraku A; Homhuan A; Kawai K; Yamamoto T; Miyazaki J; Kogure K; Yano I; Harashima H; Akaza H
    BJU Int; 2009 Mar; 103(5):686-93. PubMed ID: 19040525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined thermo-chemotherapy for recurrent bladder cancer after bacillus Calmette-Guerin.
    Nativ O; Witjes JA; Hendricksen K; Cohen M; Kedar D; Sidi A; Colombo R; Leibovitch I
    J Urol; 2009 Oct; 182(4):1313-7. PubMed ID: 19683278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.